SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001618835-21-000109
Filing Date
2021-05-13
Accepted
2021-05-13 16:14:07
Documents
1
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162093682127478.html 4  
1 FORM 4 wf-form4_162093682127478.xml 4 4043
  Complete submission text file 0001618835-21-000109.txt   5567
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130
Business Address
O'Brien Anthony Stephen (Reporting) CIK: 0001726732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36754 | Film No.: 21919789